Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bradley Martin

Concepts (327)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
40
2024
562
8.740
 Why?
Chronic Pain
17
2024
175
6.080
 Why?
Opioid-Related Disorders
17
2024
387
4.260
 Why?
Drug Overdose
10
2024
159
3.330
 Why?
Medicaid
23
2021
256
2.850
 Why?
Drug Prescriptions
14
2024
95
2.730
 Why?
Tramadol
3
2024
30
2.490
 Why?
Alcoholism
4
2022
232
2.470
 Why?
Cross-Over Studies
2
2025
223
1.810
 Why?
Retrospective Studies
38
2024
6190
1.740
 Why?
Antipsychotic Agents
9
2018
230
1.720
 Why?
Adult
56
2025
13486
1.720
 Why?
United States
49
2024
4898
1.650
 Why?
Middle Aged
54
2025
12356
1.610
 Why?
Osteoarthritis, Knee
3
2017
89
1.550
 Why?
Humans
96
2025
50201
1.480
 Why?
Pain
10
2018
373
1.460
 Why?
Adolescent
37
2025
6459
1.380
 Why?
Health Care Costs
9
2016
168
1.370
 Why?
Medication Adherence
7
2016
129
1.320
 Why?
Young Adult
27
2025
4052
1.290
 Why?
Viscosupplements
3
2017
14
1.280
 Why?
Anticoagulants
5
2023
253
1.280
 Why?
Female
66
2025
26829
1.270
 Why?
Hyaluronic Acid
3
2017
35
1.260
 Why?
Male
63
2025
25572
1.240
 Why?
Aged
38
2025
9505
1.210
 Why?
Emergency Service, Hospital
6
2016
482
1.180
 Why?
Schizophrenia
5
2009
257
1.130
 Why?
Arthroplasty, Replacement, Knee
4
2017
282
1.080
 Why?
Analgesics, Non-Narcotic
3
2012
115
1.080
 Why?
Substance-Related Disorders
5
2021
594
1.050
 Why?
Acetaminophen
4
2015
274
1.050
 Why?
Patient Compliance
6
2009
230
1.020
 Why?
Veterans
10
2024
570
0.980
 Why?
Atrial Fibrillation
3
2016
182
0.960
 Why?
Cohort Studies
14
2024
1414
0.960
 Why?
Psychotropic Drugs
1
2025
76
0.930
 Why?
Arkansas
15
2025
1988
0.920
 Why?
Suicide
1
2025
82
0.880
 Why?
Asthma
3
2015
282
0.880
 Why?
Prescription Drugs
6
2014
38
0.880
 Why?
Cost-Benefit Analysis
5
2020
270
0.860
 Why?
Insurance, Health
7
2020
131
0.830
 Why?
Venous Thromboembolism
1
2023
67
0.800
 Why?
Attention Deficit Disorder with Hyperactivity
1
2023
173
0.790
 Why?
Neck Pain
2
2021
10
0.780
 Why?
Back Pain
2
2021
38
0.770
 Why?
Drug Utilization
11
2017
75
0.760
 Why?
Central Nervous System Stimulants
1
2023
205
0.750
 Why?
Hospitalization
6
2016
665
0.750
 Why?
Arthralgia
1
2021
43
0.750
 Why?
Professional-Patient Relations
1
2021
46
0.730
 Why?
Insurance, Pharmaceutical Services
2
2019
25
0.730
 Why?
Mental Disorders
7
2025
400
0.720
 Why?
Narcotic Antagonists
2
2024
135
0.690
 Why?
Logistic Models
8
2016
901
0.690
 Why?
Naloxone
1
2020
79
0.670
 Why?
Hydrocodone
3
2024
20
0.650
 Why?
Oxycodone
3
2024
26
0.650
 Why?
Warfarin
3
2016
83
0.640
 Why?
Legislation, Drug
1
2019
17
0.640
 Why?
Contraception
1
2019
29
0.630
 Why?
Decision Support Techniques
2
2016
71
0.620
 Why?
Proton Pump Inhibitors
2
2016
84
0.620
 Why?
Adrenal Cortex Hormones
2
2017
100
0.600
 Why?
Follow-Up Studies
8
2024
2188
0.580
 Why?
Mammography
1
2018
99
0.580
 Why?
Guidelines as Topic
1
2018
110
0.570
 Why?
Buprenorphine
3
2024
144
0.570
 Why?
Practice Guidelines as Topic
3
2017
459
0.570
 Why?
Histamine H2 Antagonists
1
2016
26
0.550
 Why?
Peptic Ulcer
1
2016
14
0.550
 Why?
Purinergic P2Y Receptor Antagonists
3
2022
29
0.530
 Why?
Education, Pharmacy, Graduate
1
2016
19
0.520
 Why?
Pyridones
1
2016
35
0.520
 Why?
Risk
4
2020
315
0.510
 Why?
Inappropriate Prescribing
1
2016
21
0.510
 Why?
Safety-Based Drug Withdrawals
1
2015
7
0.510
 Why?
Dextropropoxyphene
1
2015
6
0.510
 Why?
Health Expenditures
3
2011
67
0.510
 Why?
For-Profit Insurance Plans
1
2015
2
0.500
 Why?
Brain Ischemia
2
2016
157
0.500
 Why?
Risk Factors
11
2024
3644
0.490
 Why?
Pyrazoles
1
2016
111
0.490
 Why?
Mass Screening
1
2018
348
0.480
 Why?
Quinolines
1
2015
41
0.480
 Why?
Stress, Psychological
1
2016
260
0.480
 Why?
Acetates
1
2015
49
0.480
 Why?
Time Factors
9
2018
2909
0.480
 Why?
Diabetic Neuropathies
1
2015
49
0.470
 Why?
Opiate Substitution Treatment
3
2024
94
0.470
 Why?
Anticonvulsants
2
2006
125
0.470
 Why?
Insurance Claim Reporting
2
2011
11
0.470
 Why?
Critical Illness
1
2016
301
0.460
 Why?
Insurance Claim Review
4
2010
36
0.450
 Why?
Curriculum
2
2018
397
0.450
 Why?
Pain Management
1
2015
167
0.450
 Why?
Palliative Care
1
2016
188
0.440
 Why?
Stroke
2
2016
479
0.440
 Why?
Neoplasms
1
2023
1233
0.430
 Why?
Breast Neoplasms
2
2023
1187
0.430
 Why?
Databases, Factual
8
2022
660
0.430
 Why?
Injections, Intra-Articular
3
2017
33
0.420
 Why?
Computers, Handheld
1
2013
25
0.420
 Why?
Prescription Drug Misuse
3
2024
33
0.420
 Why?
United States Department of Veterans Affairs
5
2024
287
0.410
 Why?
Age Factors
6
2018
1096
0.400
 Why?
Benzodiazepines
3
2024
70
0.400
 Why?
Cross-Sectional Studies
6
2022
1580
0.390
 Why?
Health Personnel
2
2016
250
0.370
 Why?
Community Pharmacy Services
3
2020
67
0.360
 Why?
Kidney Failure, Chronic
2
2022
199
0.340
 Why?
Case-Control Studies
6
2023
1145
0.330
 Why?
Motor Vehicles
1
2009
15
0.320
 Why?
Antidepressive Agents
2
2009
176
0.320
 Why?
Automobile Driving
1
2009
22
0.320
 Why?
Medication Errors
1
2009
25
0.320
 Why?
Pharmacists
3
2019
143
0.310
 Why?
Cost of Illness
3
2013
113
0.300
 Why?
Physicians, Primary Care
2
2018
46
0.300
 Why?
Quality-Adjusted Life Years
2
2020
63
0.300
 Why?
Pain Measurement
6
2021
246
0.300
 Why?
Health Resources
2
2012
74
0.290
 Why?
College Admission Test
2
2018
13
0.290
 Why?
Antimanic Agents
1
2007
14
0.290
 Why?
School Admission Criteria
2
2018
35
0.280
 Why?
Hypoglycemic Agents
1
2008
169
0.280
 Why?
Schools, Pharmacy
2
2018
52
0.280
 Why?
Orthopedic Procedures
2
2017
67
0.270
 Why?
Pharmaceutical Services
2
2018
52
0.270
 Why?
Propensity Score
2
2017
126
0.270
 Why?
Constipation
1
2006
33
0.270
 Why?
Overweight
1
2009
215
0.270
 Why?
Least-Squares Analysis
4
2011
42
0.260
 Why?
Medicare
4
2023
245
0.260
 Why?
Georgia
5
2006
42
0.260
 Why?
Platelet Aggregation Inhibitors
2
2021
174
0.260
 Why?
Knee Joint
2
2017
162
0.260
 Why?
Students, Pharmacy
2
2018
123
0.250
 Why?
Odds Ratio
4
2020
548
0.250
 Why?
Multivariate Analysis
3
2017
581
0.240
 Why?
Controlled Substances
1
2024
6
0.240
 Why?
Child
9
2019
6862
0.240
 Why?
Risperidone
2
2010
25
0.240
 Why?
North Carolina
5
2011
53
0.240
 Why?
Polypharmacy
1
2004
15
0.240
 Why?
Aged, 80 and over
8
2023
3158
0.230
 Why?
Drug Costs
2
2020
39
0.230
 Why?
Renal Dialysis
2
2022
171
0.220
 Why?
Haloperidol
1
2003
47
0.220
 Why?
Hemorrhage
2
2023
196
0.220
 Why?
Direct Service Costs
1
2003
5
0.210
 Why?
Irritable Bowel Syndrome
1
2003
17
0.210
 Why?
Employment
1
2003
89
0.210
 Why?
Dose-Response Relationship, Drug
5
2014
1356
0.210
 Why?
Aftercare
1
2023
74
0.210
 Why?
Prevalence
4
2018
960
0.210
 Why?
Premedication
1
2002
17
0.210
 Why?
Age Distribution
4
2018
169
0.200
 Why?
Diabetes Mellitus, Type 2
1
2008
486
0.200
 Why?
Health Services Needs and Demand
1
2004
155
0.200
 Why?
Neuralgia
1
2023
63
0.200
 Why?
Common Cold
1
2002
5
0.200
 Why?
Bronchitis
1
2002
11
0.200
 Why?
Proportional Hazards Models
4
2017
408
0.200
 Why?
Thromboembolism
1
2002
54
0.200
 Why?
Accidents
1
2021
21
0.190
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
154
0.190
 Why?
Depressive Disorder, Major
2
2020
150
0.190
 Why?
Forecasting
3
2009
145
0.190
 Why?
Ambulatory Care Facilities
1
2002
121
0.190
 Why?
Mental Health Services
1
2004
198
0.190
 Why?
Respiratory Tract Infections
1
2002
76
0.180
 Why?
Interprofessional Relations
2
2018
84
0.180
 Why?
Patient Discharge
1
2023
322
0.180
 Why?
Afghan Campaign 2001-
2
2018
40
0.180
 Why?
Administration, Oral
2
2016
432
0.180
 Why?
Obesity
1
2009
1112
0.180
 Why?
United States Food and Drug Administration
3
2011
91
0.180
 Why?
Administration, Intranasal
1
2020
30
0.170
 Why?
Markov Chains
1
2020
31
0.170
 Why?
Cardiovascular Diseases
2
2018
449
0.170
 Why?
Brain Neoplasms
1
2023
286
0.170
 Why?
Social Media
1
2022
98
0.170
 Why?
Preventive Health Services
1
2020
49
0.170
 Why?
Child, Preschool
5
2011
3896
0.160
 Why?
Regression Analysis
4
2013
395
0.160
 Why?
Insurance Coverage
1
2020
110
0.160
 Why?
Drug Administration Schedule
3
2011
369
0.160
 Why?
Sepsis
1
2021
226
0.160
 Why?
Delivery of Health Care
1
2021
308
0.160
 Why?
Health Care Surveys
2
2011
173
0.150
 Why?
Public Health Surveillance
1
2018
13
0.150
 Why?
Thiazoles
2
2016
53
0.150
 Why?
Sleep Deprivation
1
2018
16
0.150
 Why?
Papillomavirus Vaccines
1
2019
67
0.150
 Why?
Pharmacies
1
2019
60
0.150
 Why?
Physicians
1
2021
229
0.150
 Why?
Advisory Committees
1
2018
61
0.150
 Why?
Chronic Disease
5
2011
568
0.150
 Why?
Metabolic Diseases
1
2018
38
0.150
 Why?
Lung Neoplasms
1
2023
601
0.140
 Why?
Veterans Health
2
2014
62
0.140
 Why?
Molecular Weight
1
2017
85
0.140
 Why?
Acute Pain
1
2017
9
0.140
 Why?
Papillomavirus Infections
1
2019
167
0.140
 Why?
Treatment Outcome
7
2010
5203
0.140
 Why?
Educational Measurement
1
2018
204
0.140
 Why?
Monte Carlo Method
1
2016
86
0.130
 Why?
Early Detection of Cancer
1
2018
164
0.130
 Why?
Anti-Bacterial Agents
1
2002
744
0.130
 Why?
Education, Pharmacy
1
2018
144
0.130
 Why?
Health Services Accessibility
1
2020
420
0.130
 Why?
Geriatrics
1
2016
45
0.120
 Why?
Postoperative Complications
1
2002
1027
0.120
 Why?
Sulfides
1
2015
28
0.120
 Why?
Models, Theoretical
1
2016
174
0.120
 Why?
Cyclopropanes
1
2015
24
0.120
 Why?
Pyridines
1
2016
132
0.120
 Why?
Renal Insufficiency, Chronic
1
2018
170
0.120
 Why?
Thrombosis
1
2018
249
0.120
 Why?
Anti-Asthmatic Agents
1
2015
29
0.120
 Why?
Societies, Medical
1
2016
177
0.120
 Why?
Severity of Illness Index
2
2016
959
0.120
 Why?
Self Report
1
2016
202
0.120
 Why?
Long-Term Care
3
2012
50
0.120
 Why?
Health Literacy
1
2016
129
0.110
 Why?
California
2
2004
87
0.110
 Why?
Comorbidity
5
2017
612
0.110
 Why?
Risk Assessment
2
2015
1255
0.100
 Why?
Prescriptions
2
2011
10
0.100
 Why?
Monitoring, Physiologic
1
2013
127
0.100
 Why?
Sensitivity and Specificity
1
2015
871
0.100
 Why?
Guideline Adherence
2
2023
133
0.100
 Why?
Infant
3
2011
3584
0.100
 Why?
Managed Care Programs
1
2012
36
0.100
 Why?
Ticlopidine
1
2012
55
0.100
 Why?
Deductibles and Coinsurance
1
2011
2
0.090
 Why?
Hypertension, Pulmonary
1
2012
121
0.090
 Why?
Body Mass Index
2
2013
658
0.090
 Why?
Health Policy
1
2011
151
0.080
 Why?
Calibration
1
2009
58
0.080
 Why?
International Classification of Diseases
1
2009
64
0.080
 Why?
Clozapine
2
2010
26
0.080
 Why?
Reference Values
1
2009
309
0.080
 Why?
Analysis of Variance
1
2010
563
0.080
 Why?
Treatment Refusal
1
2009
35
0.080
 Why?
Evidence-Based Medicine
1
2010
247
0.080
 Why?
Carbamazepine
1
2007
13
0.070
 Why?
Mental Health
1
2010
223
0.070
 Why?
Lithium Compounds
1
2007
11
0.070
 Why?
Alendronate
1
2007
23
0.070
 Why?
Valproic Acid
1
2007
32
0.070
 Why?
Fractures, Spontaneous
1
2007
14
0.070
 Why?
Chemotherapy, Adjuvant
1
2007
121
0.070
 Why?
Osteoporosis, Postmenopausal
1
2007
28
0.070
 Why?
Affect
1
2007
98
0.070
 Why?
Drug Labeling
1
2006
11
0.070
 Why?
Bone Density Conservation Agents
1
2007
74
0.070
 Why?
Predictive Value of Tests
1
2008
921
0.060
 Why?
Adrenergic beta-Agonists
1
2005
41
0.060
 Why?
Self Disclosure
1
2005
13
0.060
 Why?
Drug Interactions
2
2018
208
0.060
 Why?
Depression
1
2009
571
0.060
 Why?
Eligibility Determination
1
2004
17
0.060
 Why?
Factor Analysis, Statistical
1
2004
76
0.060
 Why?
Urban Population
1
2005
152
0.060
 Why?
Health Surveys
2
2018
235
0.060
 Why?
Prescription Fees
1
2004
14
0.060
 Why?
Length of Stay
1
2007
627
0.060
 Why?
Algorithms
1
2007
615
0.050
 Why?
Drug Therapy, Combination
1
2004
382
0.050
 Why?
MEDLINE
1
2002
7
0.050
 Why?
Prospective Studies
1
2008
2396
0.050
 Why?
Enoxaparin
1
2002
27
0.050
 Why?
Cognition Disorders
1
2003
199
0.050
 Why?
Neuropsychological Tests
1
2003
337
0.050
 Why?
Gastrointestinal Hemorrhage
1
2022
79
0.050
 Why?
Longitudinal Studies
2
2014
700
0.050
 Why?
Data Collection
1
2002
283
0.040
 Why?
Patient Protection and Affordable Care Act
1
2020
51
0.040
 Why?
Needs Assessment
1
2020
133
0.040
 Why?
Quality of Health Care
1
2020
184
0.040
 Why?
Incidence
2
2014
1000
0.040
 Why?
Pharmacoepidemiology
1
2017
8
0.040
 Why?
Pharmacy
1
2018
54
0.040
 Why?
Universities
1
2018
169
0.040
 Why?
Vaccination
1
2019
275
0.030
 Why?
Pilot Projects
1
2019
703
0.030
 Why?
Communication
1
2018
246
0.030
 Why?
Electronic Health Records
1
2018
208
0.030
 Why?
Qualitative Research
1
2018
337
0.030
 Why?
Reminder Systems
1
2016
27
0.030
 Why?
Decision Making
1
2018
273
0.030
 Why?
Medication Therapy Management
1
2016
24
0.030
 Why?
Attitude of Health Personnel
1
2018
348
0.030
 Why?
Ischemic Attack, Transient
1
2013
56
0.030
 Why?
Lipids
1
2013
147
0.030
 Why?
Survival Analysis
1
2014
670
0.030
 Why?
Linear Models
1
2013
279
0.030
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.020
 Why?
Stress Disorders, Post-Traumatic
1
2017
377
0.020
 Why?
Diagnostic Tests, Routine
1
2012
29
0.020
 Why?
Cost Control
1
2011
13
0.020
 Why?
Acute Coronary Syndrome
1
2012
78
0.020
 Why?
Blood Pressure
1
2013
527
0.020
 Why?
Blood Glucose
1
2013
434
0.020
 Why?
Dibenzothiazepines
1
2010
10
0.020
 Why?
Adolescent Behavior
1
2011
105
0.020
 Why?
Hypnotics and Sedatives
1
2010
74
0.020
 Why?
Off-Label Use
1
2010
26
0.020
 Why?
Diabetes Mellitus
1
2013
281
0.020
 Why?
Mood Disorders
1
2009
58
0.020
 Why?
Quinolones
1
2010
42
0.020
 Why?
Anxiety Disorders
1
2009
125
0.020
 Why?
Piperazines
1
2010
118
0.020
 Why?
Headache
1
2008
76
0.020
 Why?
Sex Factors
1
2009
700
0.020
 Why?
Confidence Intervals
1
2007
155
0.020
 Why?
Probability
1
2007
164
0.020
 Why?
Drug Utilization Review
1
2005
23
0.020
 Why?
Drug Monitoring
1
2005
78
0.010
 Why?
Bone Density
1
2007
386
0.010
 Why?
Registries
1
2007
527
0.010
 Why?
Quality of Life
1
2008
843
0.010
 Why?
Reproducibility of Results
1
2005
1195
0.010
 Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (327) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department